FLIP protects cardiomyocytes from apoptosis induced by simulated ischemia/reoxygenation, as demonstrated by short hairpin-induced (shRNA) silencing of FLIP mRNA

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 11, 2003, Pages 1359-1364

  Davidson, Sean M ^a   Stephanou, Anastasis ^a   Latchman, David S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Cardiomyocytes; FLIP; Ischemia; Reperfusion

Indexed keywords

FLICE INHIBITORY PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL PROTECTION; CONTROLLED STUDY; GENE SILENCING; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; MITOCHONDRION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TISSUE OXYGENATION;

EID: 0142257955     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2003.08.001     Document Type: Article

References (28)

1. Olivetti G., Quaini F., Sala R., Lagrasta C., Corradi D., Bonacina E., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 28:1996;2005-2016.
2. Stephanou A., Brar B., Heads R., Knight R.D., Marber M.S., Pennica D., et al. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol. 30:1998;849-855.
3. Narula J., Haider N., Virmani R., Disalvo T.G., Kolodgie F.D., Hajjar R.J., et al. Apoptosis in myocytes in end-stage heart failure. New Engl J M. 335:1996;1182-1189.
4. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., et al. Apoptosis in the failing human heart. New Engl J M. 336:1997;1131-1141.
5. Jeremias I., Kupatt C., Martin-Villalba A., Habazettl H., Schenkel J., Boekstegers P., et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation. 102:2000;915-920.
6. Stephanou A., Brar B., Liao Z., Scarabelli T., Knight R.A., Latchman D.S. Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes during ischaemia versus reperfusion injury. Cell Death Differ. 8:2001;434-435.
7. Yamaguchi S., Yamaoka M., Okuyama M., Nitoube J., Fukui A., Shirakabe M., et al. Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol. 83:(A8):1999;1500-1503.
8. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol. 274:1998;R577-R595.
9. Tanaka M., Ito H., Adachi S., Akimoto H., Nishikawa T., Kasajima T., et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
10. Tschopp J., Irmler M., Thome M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol. 10:1998;552-558.
11. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., et al. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21:2002;3704-3714.
12. Suhara T., Mano T., Oliveira B.E., Walsh K. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res. 89:2001;13-19.
13. Krueger A., Baumann S., Krammer P.H., Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol. 21:2001;8247-8254.
14. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., et al. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195.
15. Rasper D.M., Vaillancourt J.P., Hadano S., Houtzager V.M., Seiden I., Keen S.L., et al. Cell death attenuation by 'Usurpin,' a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5:1998;271-288.
16. Nitobe J., Yamaguchi S., Okuyama M., Nozaki N., Sata M., Miyamoto T., et al. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res. 57:2003;119-128.
17. Imanishi T., Murry C.E., Reinecke H., Hano T., Nishio I., Liles W.C., et al. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res. 48:2000;101-110.
18. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Gene Dev. 16:2002;948-958.
19. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A., et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity. 12:2000;633-642.
20. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:1998;267-276.
21. Badorff C., Ruetten H., Mueller S., Stahmer M., Gehring D., Jung F., et al. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest. 109:2002;373-381.
22. Kataoka T., Budd R.C., Holler N., Thome M., Martinon F., Irmler M., et al. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol. 10:2000;640-648.
23. Scaffidi C., Schmitz I., Krammer P.H., Peter M.E. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem. 274:1999;1541-1548.
24. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
25. Scarabelli T.M., Stephanou A., Pasini E., Comini L., Raddino R., Knight R.A., et al. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res. 90:2002;745-748.
26. Hart S.L., Arancibia-Carcamo C.V., Wolfert M.A., Mailhos C., O'Reilly N.J., Ali R.R., et al. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther. 9:1998;575-585.
27. Brar B.K., Stephanou A., Knight R., Latchman D.S. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol. 34:2002;483-492.
28. Gavrieli Y., Sherman Y., Ben Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.